Posts tagged ‘Pathways’
Sally Church on Pharma Strategy Blog discusses a recent paper from Science and Translational Medicine, in which new research shows that endothelial cells (fibroblasts, immune cells) actively participate in regulating the cancer tumor microenvironment.
Further insight on why stromal-cancer cross talk is becoming a hot-topic, can be found on Pharma Strategy Blog.
A recent paper in The Journal of Clinical Investigation by Lee et al, presents interesting results on the use of N-terminal truncated carboxypeptidase E splice isoform as a biomarker to predict cancer metastasis.
You can read Sally Church’s analysis about whether we can predict when cancer will spread on the Pharma Strategy Blog.
Sally Church, PhD will be attending the 6th International Society of Gastroenterological Carcinogenesis (ISGC) meeting in Houston from Thursday 6th to Saturday, 8th January, 2011. Hosted by the MD Anderson Cancer Center, the meeting has an impressive line up of key opinion leaders. Further information can be found on the Pharma Strategy Blog.
Published by Sally Church on Pharma Strategy Blog
Published by Sally Church on Pharma Strategy Blog
Icarus Consultants would like to wish all our clients, friends and colleagues around the world a happy, healthy and prosperous New Year. Puisse la nouvelle année vous apporter paix, bonheur et prospérité.
This year we made a donation to GRACE, Global Resource for Cancer Education instead of mailing greeting cards.
Our office will close on Friday, December 24 2010 and reopen for business on Monday, January 3, 2011.
Published by Sally Church on Pharma Strategy Blog